Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines.
Flanagan KL, Best E, Crawford NW, Giles M, Koirala A, Macartney K, Russell F, Teh BW, Wen SC. Flanagan KL, et al. Among authors: russell f. Front Immunol. 2020 Oct 2;11:579250. doi: 10.3389/fimmu.2020.579250. eCollection 2020. Front Immunol. 2020. PMID: 33123165 Free PMC article. Review.
COVID-19, children and schools: overlooked and at risk.
Ryan KE, Goldfield S, Danchin MH, Russell F. Ryan KE, et al. Among authors: russell f. Med J Aust. 2021 Mar;214(4):189-189.e1. doi: 10.5694/mja2.50936. Med J Aust. 2021. PMID: 33641176 Free PMC article. No abstract available.
Systematic review on the impact of the pneumococcal conjugate vaccine ten valent (PCV10) or thirteen valent (PCV13) on all-cause, radiologically confirmed and severe pneumonia hospitalisation rates and pneumonia mortality in children 0-9 years old.
Reyburn R, Tsatsaronis A, von Mollendorf C, Mulholland K, Russell FM; ARI Review group. Reyburn R, et al. J Glob Health. 2023 Feb 3;13:05002. doi: 10.7189/jogh.13.05002. J Glob Health. 2023. PMID: 36734192 Free PMC article.
Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster.
Russell FM, Carapetis JR, Satzke C, Tikoduadua L, Waqatakirewa L, Chandra R, Seduadua A, Oftadeh S, Cheung YB, Gilbert GL, Mulholland EK. Russell FM, et al. Clin Vaccine Immunol. 2010 Dec;17(12):1970-6. doi: 10.1128/CVI.00117-10. Epub 2010 Oct 13. Clin Vaccine Immunol. 2010. PMID: 20943882 Free PMC article. Clinical Trial.
Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.
Russell FM, Balloch A, Licciardi PV, Carapetis JR, Tikoduadua L, Waqatakirewa L, Cheung YB, Mulholland EK, Tang ML. Russell FM, et al. Vaccine. 2011 Jun 15;29(27):4499-506. doi: 10.1016/j.vaccine.2011.04.038. Epub 2011 May 1. Vaccine. 2011. PMID: 21539882 Free PMC article. Clinical Trial.
Prevention of otitis media by vaccination.
Russell F, Mulholland K. Russell F, et al. Drugs. 2002;62(10):1441-5. doi: 10.2165/00003495-200262100-00002. Drugs. 2002. PMID: 12093313 Review.
Key lessons from the COVID-19 public health response in Australia.
Basseal JM, Bennett CM, Collignon P, Currie BJ, Durrheim DN, Leask J, McBryde ES, McIntyre P, Russell FM, Smith DW, Sorrell TC, Marais BJ. Basseal JM, et al. Among authors: russell fm. Lancet Reg Health West Pac. 2023 Jan;30:100616. doi: 10.1016/j.lanwpc.2022.100616. Epub 2022 Oct 10. Lancet Reg Health West Pac. 2023. PMID: 36248767 Free PMC article. Review.
524 results